October 16, 2020

New Drug Could Extend Life for People With ALS

FRIDAY, Oct. 16, 2020 -- An experimental drug combination lengthens survival for patients with amyotrophic lateral sclerosis (ALS), new research shows.

A previous clinical trial found that the two-drug combo -- called AMX0035 -- slowed progression of the neurodegenerative disease over six months.

October 12, 2020

8 in 10 COVID-19 Patients Suffer Neurological Symptoms, Study Finds

MONDAY, Oct. 5, 2020 -- As President Donald Trump battles the coronavirus, researchers reveal concerning new findings: Neurological symptoms occur in 8 of 10 hospitalized COVID-19 patients.

These symptoms include muscle pain, headaches, dizziness, encephalopathy and "brain fog."

September 29, 2020

1 Woman in 5 With Migraine Avoiding Pregnancy: Study

MONDAY, Sept. 21, 2020 -- Many women with severe migraines don't want to get pregnant because of concerns about their headaches, a new study finds.

Migraine, one of the world's leading causes of disability, particularly affects women of childbearing age.

September 8, 2020

Experimental Drug Shows Promise Against ALS

WEDNESDAY, Sept. 2, 2020 -- An experimental treatment may help slow the progression of the deadly brain disease amyotrophic lateral sclerosis (ALS), a new study finds.

Researchers called the results a promising step in the fight against a devastating and invariably fatal disease. And two advocacy groups are calling for swift action to make the drug available to patients.

September 8, 2020

Permanent Nerve Damage for Some COVID-19 Survivors

FRIDAY, Sept. 4, 2020 -- Placing a hospitalized COVID-19 patient in a face down position to ease breathing -- or "proning" -- has steadily gained traction as a pandemic lifesaver. But a small new study warns that it may lead to permanent nerve damage.

The concern is based on the experience of 83 COVID-19 patients who were placed face down while attached to a ventilator. Once they improved, all began post-COVID-19 rehabilitation at a single health care facility.